ID 2580 -
Szałwia lekarska
PL: Szałwia lekarska
EN: Salvia officinalis (Common Name : Sage)
Pdf: various food(s)/food constituent(s)
Oświadczenie (2)
- antyoksydacyjne
- walk przeciwko starzeniu się komórek
- oczyszczania / właściwości odtruwające
- przeciwutleniacz głównie ze względu na związki fenolowe, a także duże ilości karotenoidów i witaminy C oraz witaminy E
- skóra czynnik przeciw starzeniu anti-aging
- przeciwnowotworowe
- andioxidative zdolności
- starzenie wywołane oksydacją
- chroni skórę przed efektami przedwczesnego starzenia się
- proces starzenia się
- walka z utlenianiem i starzeniem
- anti-aging
- przeciwutleniacz
- zdrowego starzenia się
- starzeniu się komórek
- wcześniaków (skóra) starzenia się
- właściwości antyoksydacyjne
- spowalnia, obniża proces starzenia się
1.1. Ochrona komórek przed przedwczesnym starzeniem (ID 1668, 1917, 2515, 2527, 2530, 2575, 2580, 2591, 2620, 3178, 3179, 3180, 3181, 4329, 4415)
The claimed effects are “antioxidant”, “anti-cancer”, “anti-ageing”, “healthy ageing”, “antioxidant mainly due to phenolic compounds as well as high amounts of carotenoids and vitamin C and E” and “skin anti-ageing agent”. The Panel assumes that the target population is the general population.
The proposed wordings and clarifications provided by Member States include “lowers the ageing process”, “fighting oxidation induced ageing”, “fights against cellular ageing”, and “protects the skin from the effects of premature ageing”.
The Panel considers that the claimed effect “anti-cancer” relates to the prevention of a disease and does not comply with the criteria laid down in Regulation (EC) No 1924/2006.
No definition has been provided of “premature (skin) ageing”, “healthy ageing”, “oxidation-induced ageing”, “ageing process” or “cellular ageing” in relation to the antioxidant properties of foods.
The Panel considers that the claimed effects are general and non-specific and do not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
1.2. Aktywność antyoksydacyjna, zawartość antyoksydantów, właściwości antyoksydacyjne (ID 857, 1306, 2515, 2527, 2530, 2575, 2580, 2591, 2629, 2728, 4327, 4365, 4380, 4390, 4394, 4455, 4464, 4507, 4694, 4705)
The claimed effects are “antioxidant”, “andioxidative capacity”, “antioxidant properties”, “antioxidant activity”, “purifying/ detoxifying properties” and “antioxidant effect”. The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effect refers to the capacity of foods/food constituents to scavenge free radicals and/or to their reducing capacity.
The Panel considers that claims made on the antioxidant capacity/content or properties of foods/food constituents based on their capability of scavenging free radicals in vitro refer to a property of the food/food constituent measured in model systems, and that the information provided does not establish that this capability as such exerts a beneficial physiological effect in humans.
The Panel considers that no evidence has been provided to establish that having antioxidant activity/content and/or antioxidant properties is a beneficial physiological effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of this opinion and a beneficial physiological effect related to antioxidant activity, antioxidant content or antioxidant properties.
Warunki i możliwe ograniczenia stosowania oświadczenia
Feuille
6x150mg/jour